CBD

CBD, Regulation

FDA Issues More CBD Warning Letters, With a Focus on Covid Claims

The 2018 Farm Bill legalized hemp, and, by extension, hemp-derived CBD, but the Food and Drug Administration has not yet released rules to guide the growing industry.

CBD, Regulation

FDA Reiterates Need for Cannabinoid Data in Webinar on Research and Regulation

The Food and Drug Administration has said for years that it is working on rules for cannabinoid-containing products. But it has also said that crucial research and data are lacking.

CBD, Regulation

FDA: The Cannabis Regulatory Landscape is “Complex”

A policy coordinator with the FDA’s Cannabis Product Committee spoke about CBD during a Food and Drug Law Institute event focused on cannabis.

CBD, Regulation

FDA Launches Biggest Cannabis Data Collection Plan Yet

The Food and Drug Administration has been on a march to collect cannabinoid-related data. The “Cannabis-Derived Products Data Acceleration Plan” released this month is its most robust effort.

CBD, Regulation

FDA Rejects Two Applications for CBD-based Dietary Supplements

Epidiolex strikes again: the FDA-approved CBD-based pharmaceutical is complicating other uses of CBD.

CBD, Regulation

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.

CBD, Regulation

Consumer Brands Association Pushes Lawmakers on CBD Amid FDA Inaction

The group, which includes Coca-Cola and Kellogg’s as members, says its membership is “CBD curious” but that the lack of federal regulation is keeping major brands at bay.

CBD, Regulation

Hemp in Animal Food: Is a Path Taking Shape?

“I’m getting very hopeful that we're headed down the road to seeing some hemp-derived ingredients approved for use in animal food,” said the FDA’s Deputy Director in the Division of Animal Feeds.

CBD, Regulation

Amid Pressure to Publish CBD Rules, FDA Reiterates Need for “Better Data”

The FDA, which has been crafting rules for CBD products since 2019, says it is seeking partnerships, from academia to government and the cannabis industry, to “develop the foundation for more robust CBD data collection.”

CBD, Regulation

FDA, DOJ Officials Talk Cannabis and CBD at Food and Drug Conference

The Food and Drug Law Institute is hosting officials from several federal agencies this week to discuss cannabis policies.

CBD, Regulation

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.

CBD, Regulation

The FDA Wants to Help Cannabis Businesses Advance Research

During a recent webinar, the FDA detailed how its Drug Master Files process could speed up research, while keeping proprietary information secret.

CBD, Regulation

Here’s What Else We Know About the White House Meetings on CBD

Among the new names on the list of entities seeking to discuss the FDA’s forthcoming rules on CBD products: American Bankers Association and Columbia Care.

CBD, Regulation

FDA Approves Epidiolex for New Condition That Causes Benign Tumors, Seizures

Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.

CBD, Regulation

Hemp Groups to Meet with White House on FDA CBD Policy

The Food and Drug Administration drafted its long-awaited CBD policy, and sent it to the White House Office of Management and Budget for approval, a final step before publication.

CBD, Regulation

Federal DOT Discusses Hemp Legalization’s Impact on Commercial Drivers

The US Department of Transportation committee heard a presentation and asked questions about how the passage of the 2018 Farm Bill, and proliferation of CBD, is affecting the nation’s commercial drivers.